Table 4 Grade III–IV complications of pc-RPLND according to Clavien-Dindo classification in relation to clinical factors
Clinical factor evaluated | Eligible total (n) | Categories (eligible in category, n) | Patients with complications (n), (%) | p valueb |
|---|---|---|---|---|
Age | 143 | ≤ 30 years (n = 76) | 10 (13.2%) | 0.59 |
> 30 years (n = 67) | 11 (16.4% | |||
BMI | 131 | ≤ 29 kg/m2 (n = 103) | 12 (11.7%) | 0.18 |
≥ 30 kg/m2 (n = 28) | 6 (21.4%) | |||
Laterality of primary | 137 | Right-sided (n = 68) | 6 (8.8%) | 0.06 |
Left-sided (n = 69) | 14 (20.3%) | |||
Duration of surgery | 67 | ≤ 269 min (n = 34) | (0%) | 0.001 |
≥ 270 min (n = 33) | 9 (27.3%) | |||
Cisplatin dosage | 93 | < 500 mg (n = 18) | 2 (11.1%) | 0.83 |
500–700 mg (n = 45) | 4 (8.9%) | |||
> 700mg (n = 30) | 4 (13.3%) | |||
Number of resection fields a | 139 | ≤ 5 (n = 82) | 10 (12.2%) | 0.54 |
> 5 (n = 57) | 9 (15.8%) | |||
Teratoma in primary | 92 | Yes (n = 18) | 2 (11.1%) | 0.83 |
No (n = 74) | 7 (9.5%) | |||
Histology of resected specimen | 145 | Necrosis/fibrosis (n = 64) | 7 (10.9% | 0.02 |
Teratoma (n = 65) | 8 (12.3%) | |||
Viable cancer (n = 16) | 6 (37.5%) |